Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes novel coronavirus disease (COVID-19), is the seventh pathogenic coronavirus recently discovered in December 2019 in Wuhan, China. To date, our knowledge about its effect on the human host remains limited. It is well known that host genetic factors account for the individual differences in the susceptibility to infectious diseases. The genetic susceptibility factors to COVID-19 and its severity are associated with several unanswered questions. However, the experience gained from an earlier strain of coronavirus, SARS-CoV-1, which shows 78% genetic similarity to SARS-CoV-2 and uses the same receptor to bind to host cells, could provide some clues. It, therefore, seems possible to assemble new evidence in order to solve a potential genetic predisposition puzzle for COVID-19. In this chapter, the puzzle pieces, including virus entry receptors, immune response, and inflammation-related genes, as well as the probable genetic predisposition models to COVID-19, are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abrams EM, Szefler SJ (2020) Managing Asthma during COVID-19: an example for other chronic conditions in children and adolescents. J Pediatr 222:221
Abrams EM, Geert W‘J, Yang CL (2020) Asthma and COVID-19. CMAJ 192:E551
Aghili N, Devaney JM, Alderman LO, Zukowska Z, Epstein SE, Burnett MS (2012) Polymorphisms in dipeptidyl peptidase IV gene are associated with the risk of myocardial infarction in patients with atherosclerosis. Neuropeptides 46:367–371
Ahanchian H, Moazzen N, Faroughi MSD, Khalighi N, Khoshkhui M, Aelami MH, Haghi NSM, Rezaei N (2020) COVID-19 in a child with primary specific antibody deficiency. https://doi.org/10.21203/rs.3.rs-28155/v1
Ahmadi M, Saffarzadeh N, Habibi MA, Hajiesmaeili F, Rezaei N (2020) Colon cancer and SARS-CoV-2: impact of ACE2 expression in susceptibility to COVID-19. bioRxiv. https://doi.org/10.1101/2020.06.11.146878
Ahmed RH, Huri HZ, Al-Hamodi Z, Salem SD, Al-absi B, Muniandy S (2016) Association of DPP4 gene polymorphisms with type 2 diabetes mellitus in Malaysian subjects. PLoS One 11:e0154369
Ascough S, Paterson S, Chiu C (2018) Induction and subversion of human protective immunity: contrasting influenza and respiratory syncytial virus. Front Immunol 9:323
Asselta R, Paraboschi EM, Mantovani A, Duga S (2020) ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Aging 12:10087
Bahrami A, Vafapour M, Moazzami B, Rezaei N (2020) Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: first case from Iran. J Paediatr Child Health. https://doi.org/10.1111/jpc.15048
Barreiro LB, Patin E, Neyrolles O, Cann HM, Gicquel B, Quintana-Murci L (2005) The heritage of pathogen pressures and ancient demography in the human innate-immunity CD209/CD209L region. Am J Hum Genet 77:869–886
Basiri A, Pazhouhnia Z, Beheshtizadeh N, Hoseinpour M, Saghazadeh A, Rezaei N (2020) Regenerative medicine in COVID-19 treatment: real opportunities and range of promises. Stem Cell Rev Rep 16:1–13
Baudin B (2002) New aspects on angiotensin-converting enzyme: from gene to disease. Clin Chem Lab Med 40:256–265
Ben-Ari Z, Mor E, Papo O, Kfir B, Sulkes J, Tambur AR, Tur-Kaspa R, Klein T (2003) Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 98:144–150
Bergeron E, Vincent MJ, Wickham L, Hamelin J, Basak A, Nichol ST, Chrétien M, Seidah NG (2005) Implication of proprotein convertases in the processing and spread of severe acute respiratory syndrome coronavirus. Biochem Biophys Res Commun 326:554–563
Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, Walmsley SL, Mazzulli T, Avendano M, Derkach P (2003) Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 289:2801–2809
Böttcher E, Matrosovich T, Beyerle M, Klenk H-D, Garten W, Matrosovich M (2006) Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J Virol 80:9896–9898
Brun P, Tarricone E, Di Stefano A, Mattiuzzo E, Mehrbod P, Ghavami S, Leonardi A (2020) The regulatory activity of autophagy in conjunctival fibroblasts and its possible role in vernal keratoconjunctivitis. J Allergy Clin Immunol 146:1210-1213.e9
Burgner D, Jamieson SE, Blackwell JM (2006) Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better? Lancet Infect Dis 6:653–663
Cai H (2020) Sex difference and smoking predisposition in patients with COVID-19. Lancet Respir Med 8:e20
Cameron MJ, Ran L, Xu L, Danesh A, Bermejo-Martin JF, Cameron CM, Muller MP, Gold WL, Richardson SE, Poutanen SM (2007) Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol 81:8692–8706
Canna SW, Behrens EM (2012) Making sense of the cytokine storm: a conceptual framework for understanding, diagnosing, and treating hemophagocytic syndromes. Pediatr Clin 59:329–344
Cao Y, Li L, Feng Z, Wan S, Huang P, Sun X, Wen F, Huang X, Ning G, Wang W (2020) Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov 6:1–4
Chan KCA, Tang NLS, Hui DSC, Chung GTY, Wu AKL, Chim SSC, Chiu RWK, Lee N, Choi KW, Sung YM (2005) Absence of association between angiotensin converting enzyme polymorphism and development of adult respiratory distress syndrome in patients with severe acute respiratory syndrome: a case control study. BMC Infect Dis 5:26
Chan VSF, Chan KYK, Chen Y, Poon LLM, Cheung ANY, Zheng B, Chan K-H, Mak W, Ngan HYS, Xu X (2006) Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection. Nat Genet 38:38–46
Chan KYK, Xu M-S, Ching JCY, So TMK, Lai S-T, Chu C-M, Yam LYC, Wong ATY, Chung PH, Chan VSF (2010a) CD209 (DC-SIGN)− 336A> G promoter polymorphism and severe acute respiratory syndrome in Hong Kong Chinese. Hum Immunol 71:702–707
Chan KY, Xu MS, Ching JC, Chan VS, Ip YC, Yam L, Chu CM, Lai ST, So KM, Wong TY (2010b) Association of a single nucleotide polymorphism in the CD209 (DC-SIGN) promoter with SARS severity. Hong Kong Med J = Xianggang yi xue za zhi 16:37
Chen Z, Mi L, Xu J, Yu J, Wang X, Jiang J, Xing J, Shang P, Qian A, Li Y (2005) Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus. J Infect Dis 191:755–760
Chiu RWK, Tang NLS, Hui DSC, Chung GTY, Chim SSC, Chan KCA, Sung Y-m, Chan LYS, Tong Y-k, Lee W-s (2004) ACE2 gene polymorphisms do not affect outcome of severe acute respiratory syndrome. Clin Chem 50:1683–1686
Cui J, Li F, Shi Z-L (2019) Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 17:181–192
Darbeheshti F, Rezaei N (2020) Genetic predisposition models to COVID-19 infection. Med Hypotheses 142:109818
Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S (2020) Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics 145:e20200702
Eghtedardoost M, Ghazanfari T, Sadeghipour A, Hassan ZM, Ghanei M, Ghavami S (2020) Delayed effects of sulfur mustard on autophagy suppression in chemically-injured lung tissue. Int Immunopharmacol 80:105896
Emami A, Shojaei S, da Silva Rosa SC, Aghaei M, Samiei E, Vosoughi AR, Kalantari F, Kawalec P, Thliveris J, Sharma P, Zeki AA, Akbari M, Gordon JW, Ghavami S (2019) Mechanisms of simvastatin myotoxicity: the role of autophagy flux inhibition. Eur J Pharmacol 862:172616
Engler RJM, Klote MM, Spooner CE, Reardon GT, Halsey JF, Nelson MR (2010) Mannan-binding lectin (MBL) serum levels in a healthy adult population: gender differences in prevalence of MBL deficiency. J Allergy Clin Immunol 125:AB10
Ezekowitz RA (2003) Role of the mannose-binding lectin in innate immunity. J Infect Dis 187:S335–SS39
Fathi N, Rezaei N (2020) Lymphopenia in COVID-19: therapeutic opportunities. Cell Biol Int 44:1792
Feng B, Mao Z-r, Pang K, Zhang S-l, Li L (2015) Association of tumor necrosis factor α− 308G/A and interleukin-6− 174G/C gene polymorphism with pneumonia-induced sepsis. J Crit Care 30:920–923
Fernández-Arcás N, Blanco A, Jesus Gaitan M, Nyqvist M, Alonso A, Reyes-Engel A (2004) Differential transcriptional expresion of the polymorphic myxovirus resistance protein A in response to interferon-alpha treatment. Pharmacogenet Genomics 14:189–193
Flores C, Ma S-F, Maresso K, Wade MS, Villar J, Garcia JGN (2008) IL6 gene-wide haplotype is associated with susceptibility to acute lung injury. Transl Res 152:11–17
Garred P, Madsen HO, Balslev U, Hofmann BO, Pedersen C, Gerstoft J, Svejgaard A (1997) Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet 349:236–240
Glowacka I, Bertram S, Müller MA, Allen P, Soilleux E, Pfefferle S, Steffen I, Tsegaye TS, He Y, Gnirss K (2011) Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol 85:4122–4134
Hamano E, Hijikata M, Itoyama S, Quy T, Phi NC, Long HT, Van Ban V, Matsushita I, Yanai H, Kirikae F (2005) Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population. Biochem Biophys Res Commun 329:1234–1239
Hanaei S, Rezaei N (2020) COVID-19: developing from an outbreak to a pandemic. Arch Med Res 51:582
Hartshorn KL, Sastry K, White MR, Anders EM, Super M, Ezekowitz RA, Tauber AI (1993) Human mannose-binding protein functions as an opsonin for influenza A viruses. J Clin Invest 91:1414–1420
Hibberd ML, Sumiya M, Summerfield JA, Booy R, Levin M, Meningococcal Research Group (1999) Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Lancet 353:1049–1053
Hill AVS (2012) Evolution, revolution and heresy in the genetics of infectious disease susceptibility. Philos Trans R Soc B: Biol Sci 367:840–849
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271
Huang K-J, Ih-Jen S, Theron M, Wu Y-C, Lai S-K, Liu C-C, Lei H-Y (2005) An interferon-γ-related cytokine storm in SARS patients. J Med Virol 75:185–194
Hui XU, Zhiming B, Walsh M (2020) Four deaths in one family show danger of Wuhan home quarantine policy. Available at: https://www.caixinglobal.com
Ip WKE, Chan KH, Law HKW, Tso GHW, Kong EKP, Wong WHS, To YF, Yung RWH, Chow EY, Au KL (2005) Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis 191:1697–1704
Itoyama S, Keicho N, Quy T, Phi NC, Long HT, Van Ban V, Ohashi J, Hijikata M, Matsushita I, Kawana A (2004) ACE1 polymorphism and progression of SARS. Biochem Biophys Res Commun 323:1124–1129
Iwata-Yoshikawa N, Okamura T, Shimizu Y, Hasegawa H, Takeda M, Nagata N (2019) TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection. J Virol 93:e01815–e01818
Jabbari P, Jabbari F, Ebrahimi S, Rezaei N (2020) COVID-19: a chimera of two pandemics. Disaster Med Public Health Prep 14:1–3
Jahanshahlu L, Rezaei N (2020a) Central nervous system involvement in COVID-19. Arch Med Res 51:721
Jahanshahlu L, Rezaei N (2020b) Monoclonal antibody as a potential anti-COVID-19. Biomed Pharmacother 129:110337
Jerrard-Dunne P, Sitzer M, Risley P, Steckel DA, Buehler A, von Kegler S, Markus HS (2003) Interleukin-6 promoter polymorphism modulates the effects of heavy alcohol consumption on early carotid artery atherosclerosis: the Carotid Atherosclerosis Progression Study (CAPS). Stroke 34:402–407
Jiang Y, Xu J, Zhou C, Wu Z, Zhong S, Liu J, Luo W, Chen T, Qin Q, Deng P (2005) Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med 171:850–857
Johnston SL (2020) Asthma and COVID-19: is asthma a risk factor for severe outcomes? Allergy 75:1543
Kafieh R, Arian R, Saeedizadeh N, Minaee S, Yadav SK, Vaezi A, Rezaei N, Javanmard SH (2020) COVID-19 in Iran: a deeper look into the future. medRxiv. https://doi.org/10.1101/2020.04.24.20078477
Karlberg J, Chong DSY, Lai WYY (2004) Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? Am J Epidemiol 159:229–231
Keicho N, Itoyama S, Kashiwase K, Phi NC, Long HT, Van Ban V, Hoa BK, Le Hang NT, Hijikata M, Sakurada S (2009) Association of human leukocyte antigen class II alleles with severe acute respiratory syndrome in the Vietnamese population. Hum Immunol 70:527–531
Kenney AD, Dowdle JA, Bozzacco L, McMichael TM, St. Gelais C, Panfil AR, Sun Y, Schlesinger LS, Anderson MZ, Green PL (2017) Human genetic determinants of viral diseases. Annu Rev Genet 51:241–263
Kleine-Weber H, Schroeder S, Krüger N, Prokscha A, Naim HY, Müller MA, Drosten C, Pöhlmann S, Hoffmann M (2020) Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus. Emerg Microbes Infect 9:155–168
Knapp S, Yee LJ, Frodsham AJ, Hennig BJW, Hellier S, Zhang L, Wright M, Chiaramonte M, Graves M, Thomas HC (2003) Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun 4:411–419
Law HKW, Cheung CY, Ng HY, Sia SF, Chan YO, Luk W, Nicholls JM, Peiris JSM, Lau YL (2005) Chemokine up-regulation in sars-coronavirus–infected, monocyte-derived human dendritic cells. Blood 106:2366–2374
Letko MC, Munster V (2020) Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nature microbiology 5:562–9.
Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450–454
Li H, Tang NLS, Chan PKS, Wang CY, Hui DSC, Luk C, Kwok R, Huang W, Sung JJY, Kong QP (2008) Polymorphisms in the C-type lectin genes cluster in chromosome 19 and predisposition to severe acute respiratory syndrome coronavirus (SARS-CoV) infection. J Med Genet 45:752–758
Li Y, Zhang Z, Yang L, Lian X, Xie Y, Li S, Xin S, Cao P, Lu J (2020) The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike. iScience 23:101160
Lim W, Peiris JSM, Lau YL, Chong WP, Ip WKE, Chow EY, Au KL, Tso GHW, Yung RWH, Ng MW (2006) The interferon gamma gene polymorphism+ 874 A/T is associated with severe acute respiratory syndrome. BMC Infect Dis 6:82
Lin M, Tseng H-K, Trejaut JA, Lee H-L, Loo J-H, Chu C-C, Chen P-J, Su Y-W, Lim KH, Tsai Z-U (2003) Association of HLA class I with severe acute respiratory syndrome coronavirus infection. BMC Med Genet 4:9
Lotfi M, Rezaei N (2020) SARS-CoV-2: a comprehensive review from pathogenicity of the virus to clinical consequences. J Med Virol 92:1864
Lotfi M, Hamblin MR, Rezaei N (2020) COVID-19: transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta 508:254
Lu X-M, Chen G-J, Yang Y, Qiu H-B (2011) Angiotensin-converting enzyme polymorphism affects outcome of local Chinese with acute lung injury. Respir Med 105:1485–1490
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395:565–574
Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP, Svejgaard A (1995) Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 155:3013–3020
Mahdavinia M, Foster KJ, Jauregui E, Moore D, Adnan D, Andy-Nweye AAB, Khan S, Bishehsari F (2020) Asthma prolongs intubation in COVID-19. J Allergy Clin Immunol Pract 8:2388
Mao Z-R, Zhang S-L, Feng B (2017) Association of IL-10 (-819T/C,-592A/C and-1082A/G) and IL-6-174G/C gene polymorphism and the risk of pneumonia-induced sepsis. Biomarkers 22:106–112
Martin LJ, Gupta J, Jyothula SS, Butsch Kovacic M, Biagini Myers JM, Patterson TL, Ericksen MB, He H, Gibson AM, Baye TM, Amirisetty S, Tsoras AM, Sha Y, Eissa NT, Hershey GK (2012) Functional variant in the autophagy-related 5 gene promotor is associated with childhood asthma. PLoS One 7:e33454
McAlinden KD, Kota A, Haghi M, Ghavami S, Sharma P (2020) Pharmacologic inhibition of vacuolar H(+)ATPase attenuates features of severe Asthma in mice. Am J Respir Cell Mol Biol 62:117–120
McDermott DH, Yang Q, Kathiresan S, Adrienne Cupples L, Massaro JM, Keaney JF Jr, Larson MG, Vasan RS, Hirschhorn JN, O’Donnell CJ (2005) CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study. Circulation 112:1113–1120
Mirbeyk M, Rezaei N (2020) The impact of COVID-19 on pregnancy and neonatal health: a systematic review. https://doi.org/10.21203/rs.3.rs-25861/v1
Moazzami B, Razavi-Khorasani N, Moghadam AD, Farokhi E, Rezaei N (2020) COVID-19 and telemedicine: immediate action required for maintaining healthcare providers well-being. J Clin Virol 126:104345
Mohamed K, Rodríguez-Román E, Rahmani F, Zhang H, Ivanovska M, Makka SA, Joya M, Makuku R, Islam MS, Radwan N (2020a) Borderless collaboration is needed for COVID-19—A disease that knows no borders. Infect Control Hosp Epidemiol 41:1–2
Mohamed K, Yazdanpanah N, Saghazadeh A, Rezaei N (2020b) Computational drug discovery and repurposing for the treatment of Covid-19: a systematic review. Available at SSRN 3583748
Momtazmanesh S, Ochs HD, Uddin LQ, Perc M, Routes JM, Vieira DN, Al-Herz W, Baris S, Prando C, Rosivall L (2020) All together to Fight COVID-19. Am J Trop Med Hyg 102:1181–1183
Moradian N, Ochs HD, Sedikies C, Hamblin MR, Camargo CA, Alfredo Martinez J, Biamonte JD, Abdollahi M, Torres PJ, Nieto JJ (2020) The urgent need for integrated science to fight COVID-19 pandemic and beyond. J Transl Med 18:1–7
Moriuchi H, Moriuchi M, Fauci AS (1997) Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J Immunol 158:3483–3491
Nasab MG, Saghazadeh A, Rezaei N (2020) SARS-CoV-2–a tough opponent for the immune system. Arch Med Res 51:589
Ng MHL, Lau K-M, Li L, Cheng S-H, Chan WY, Hui PK, Zee B, Leung C-B, Sung JJY (2004) Association of human-leukocyte-antigen class I (B* 0703) and class II (DRB1* 0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome. J Infect Dis 190:515–518
Ng MW, Zhou G, Chong WP, Lee LWY, Law HKW, Zhang H, Wong WHS, Fok SFS, Zhai Y, Yung RWH (2007) The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese. BMC Infect Dis 7:50
Peiris JSM, Lai ST, Poon LLM, Guan Y, Yam LYC, Lim W, Nicholls J, Yee WKS, Yan WW, Cheung MT (2003) Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361:1319–1325
Pennington E (2020) Asthma increases risk of severity of COVID-19. Cleve Clin J Med. https://doi.org/10.3949/ccjm.87a.ccc002
Pham DL, Kim SH, Losol P, Yang EM, Shin YS, Ye YM, Park HS (2016) Association of autophagy related gene polymorphisms with neutrophilic airway inflammation in adult asthma. Korean J Intern Med 31:375–385
Pravica V, Perrey C, Stevens A, Lee J-H, Hutchinson IV (2000) A single nucleotide polymorphism in the first intron of the human IFN-γ gene:: absolute correlation with a polymorphic CA microsatellite marker of high IFN-γ production. Hum Immunol 61:863–866
Rabiee N, Rabiee M, Bagherzadeh M, Rezaei N (2020) COVID-19 and picotechnology: potential opportunities. Med Hypotheses 144:109917
Raj VS, Mou H, Smits SL, Dekkers DHW, Müller MA, Dijkman R, Muth D, Demmers JAA, Zaki A, Fouchier RAM (2013) Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495:251–254
Ren L-L, Wang Y-M, Wu Z-Q, Xiang Z-C, Guo L, Xu T, Jiang Y-Z, Xiong Y, Li Y-J, Li X-W (2020) Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J 133:1015
Rezaei N (2020a) COVID-19 affects healthy pediatricians more than pediatric patients. Infect Control Hosp Epidemiol 41:1–1
Rezaei N (2020b) COVID-19 and medical biotechnology. Avicenna J Med Biotechnol 12:139
Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343–1346
Roy S, Knox K, Segal S, Griffiths D, Moore CE, Welsh KI, Smarason A, Day NP, McPheat WL, Crook DW (2002) MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet 359:1569–1573
Rzymski P, Nowicki M, Mullin GE, Abraham A, Rodríguez-Román E, Petzold MB, Bendau A, Sahu KK, Ather A, Naviaux A-F (2020) Quantity does not equal quality: Scientific principles cannot be sacrificed. Int Immunopharmacol 86:106711
Saghazadeh A, Rezaei N (2020a) Immune-epidemiological parameters of the novel coronavirus–a perspective. Expert Rev Clin Immunol 16:1–6
Saghazadeh A, Rezaei N (2020b) Towards treatment planning of COVID-19: rationale and hypothesis for the use of multiple immunosuppressive agents: anti-antibodies, immunoglobulins, and corticosteroids. Int Immunopharmacol 84:106560
Sahu KK, Siddiqui AD, Rezaei N, Cerny J (2020) Challenges for management of immune thrombocytopenia during COVID-19 pandemic. J Med Virol 92:2277
Saleki K, Banazadeh M, Saghazadeh A, Rezaei N (2020) The involvement of the central nervous system in patients with COVID-19. Rev Neurosci 31:453
Schork NJ, Murray SS, Frazer KA, Topol EJ (2009) Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 19:212–219
Shao S, Xu QQ, Yu X, Pan R, Chen Y (2020) Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions. Pharmacol Ther 209:107503
Shen C, Jiao W-W, Feng W-X, Wu X-R, Xiao J, Miao Q, Sun L, Wang B-B, Wang J, Liu F (2013) IFNG polymorphisms are associated with tuberculosis in Han Chinese pediatric female population. Mol Biol Rep 40:5477–5482
Shirogane Y, Takeda M, Iwasaki M, Ishiguro N, Takeuchi H, Nakatsu Y, Tahara M, Kikuta H, Yanagi Y (2008) Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2. J Virol 82:8942–8946
Shojaei S, Koleini N, Samiei E, Aghaei M, Cole LK, Alizadeh J, Islam MI, Vosoughi AR, Albokashy M, Butterfield Y, Marzban H, Xu F, Thliveris J, Kardami E, Hatch GM, Eftekharpour E, Akbari M, Hombach-Klonisch S, Klonisch T, Ghavami S (2020) Simvastatin increases temozolomide-induced cell death by targeting the fusion of autophagosomes and lysosomes. FEBS J 287:1005–1034
Stawiski EW, Diwanji D, Suryamohan K, Gupta R, Fellouse FA, Sathirapongsasuti F, Liu J, Jiang Y-P, Ratan A, Mis M (2020) Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility. bioRxiv. https://doi.org/10.1101/2020.04.07.024752
Strollo R, Pozzilli P (2020) DPP4 inhibition: preventing SARS-CoV-2 infection and/or progression of COVID-19? Diabetes Metab Res Rev 36:e3330
Suzuki F, Arase Y, Suzuki Y, Tsubota A, Akuta N, Hosaka T, Someya T, Kobayashi M, Saitoh S, Ikeda K (2004) Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection. J Viral Hepat 11:271–276
Tang F, Liu W, Zhang F, Xin Z-T, Wei M-T, Zhang P-H, Yang H, Ly H, Cao W-C (2008) IL-12 RB1 genetic variants contribute to human susceptibility to severe acute respiratory syndrome infection among Chinese. PLoS One 3:e2183
Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, Franco JL, Holland SM, Klein C, Morio T (2020) Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee. J Clin Immunol 40:24–64
Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ (2000) A human homolog of angiotensin-converting enzyme cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275:33238–33243
Tong Y, Wang Z, Geng Y, Liu J, Zhang R, Lin Q, Li X, Huang D, Gao S, Hu D (2010) The association of functional polymorphisms of IL-6 gene promoter with ischemic stroke: analysis in two Chinese populations. Biochem Biophys Res Commun 391:481–485
Tso HW, Ip WK, Chong WP, Tam CM, Chiang AKS, Lau YL (2005) Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese. Genes Immun 6:358–363
Tu X, Chong WP, Zhai Y, Zhang H, Zhang F, Wang S, Liu W, Wei M, Siu NHO, Yang H (2015) Functional polymorphisms of the CCL2 and MBL genes cumulatively increase susceptibility to severe acute respiratory syndrome coronavirus infection. J Infect 71:101–109
Ulhaq ZS, Soraya GV (2020) Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia. Available at SSRN 3592878
Vaninov N (2020) In the eye of the COVID-19 cytokine storm. In: Nature Publishing Group
Wang H, Zhang K, Qin H, Yang L, Zhang L, Cao Y (2015) Genetic association between CD143 rs4340 polymorphism and pneumonia risk: a meta analysis. Medicine 94:e883
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y (2020a) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 323:1061–1069
Wang K, Chen W, Zhou Y-S, Lian J-Q, Zhang Z, Du P, Gong L, Zhang Y, Cui H-Y, Geng J-J (2020b) SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. bioRxiv
Wong CK, Lam CWK, Wu AKL, Ip WK, Lee NLS, Chan IHS, Lit LCW, Hui DSC, Chan MHM, Chung SSC (2004) Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 136:95–103
Xiong P, Zeng X, Song MS, Jia SW, Zhong MH, Xiao LL, Lan W, Cai C, Wu XW, Gong FL (2008) Lack of association between HLA-A,-B and-DRB1 alleles and the development of SARS: a cohort of 95 SARS-recovered individuals in a population of Guangdong, southern China. Int J Immunogenet 35:69–74
Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, Li T, Chen Q (2020) High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 12:1–5
Yan J, Mao Y, Wang C, Wang Z (2015) Association study between an SNP in CD147 and its expression with acute coronary syndrome in a Jiangsu Chinese population. Medicine 94:e1537
Yang IA, Seeney SL, Wolter JM, Anders EM, McCormack JG, Tunnicliffe AM, Rabnott GC, Shaw JG, Dent AG, Kim ST (2003) Mannose-binding lectin gene polymorphism predicts hospital admissions for COPD infections. Genes Immun 4:269–274
Yazdanpanah F, Hamblin MR, Rezaei N (2020) The immune system and COVID-19: friend or foe? Life Sci 256:117900
Yousefzadegan S, Rezaei N (2020) Case report: death due to COVID-19 in three brothers. Am J Trop Med Hyg 102:1203–1204
Zeki AA, Yeganeh B, Kenyon NJ, Post M, Ghavami S (2016) Autophagy in airway diseases: a new frontier in human asthma? Allergy 71:5–14
Zhang H, Zhou G, Zhi L, Yang H, Zhai Y, Dong X, Zhang X, Gao X, Zhu Y, He F (2005) Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection. J Infect Dis 192:1355–1361
Zhang M, Lu Y, Zhang X, Lu A, Wang L, Chen C (2016) I nterleukin-4 polymorphism is associated with severity of respiratory syncytial virus infection. J Paediatr Child Health 52:25–29
Zhi L, Zhou G, Zhang H, Zhai Y, Yang H, Zhang F, Wang S, Wei M, Cao W, He F (2007) Lack of support for an association between CLEC4M homozygosity and protection against SARS coronavirus infection. Nat Genet 39:692–693
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Darbeheshti, F. et al. (2021). Coronavirus: Pure Infectious Disease or Genetic Predisposition. In: Rezaei, N. (eds) Coronavirus Disease - COVID-19. Advances in Experimental Medicine and Biology, vol 1318. Springer, Cham. https://doi.org/10.1007/978-3-030-63761-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-63761-3_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-63760-6
Online ISBN: 978-3-030-63761-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)